FIELD: biotechnology.
SUBSTANCE: vaccine strain of the influenza virus, Ortomyxoviridae, genus Influenza, A/17/Anui/2013/61 (H7N9) is deposited in the State Collection of Viruses FSBI D. I. Ivanovsky Scientific Research Institute of Virology under number 2738.
EFFECT: vaccine strain is characterised by the combination of such useful features as the antigenic specificity of the epidemic virus, the genome structure, optimal for reassortant vaccine strains, temperature sensitivity and cold-adapting, harmlessness for ferrets, which correlates with attenuation for a human, characteristic donor attenuation, as well as immunogenicity.
5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/HONGKONG/2017/75108 (H7N9) FOR PRODUCING POTENTIALLY PANDEMIC LIVE INTRANASAL INFLUENZA VACCINE | 2018 |
|
RU2685121C1 |
| REASSORTANT INFLUENZA VIRUS STRAIN RN9/13-HUMAN A(H6N9) FOR NEURAMINIDASE ANTIBODY ASSAY IN INFLUENZA INFECTION AND VACCINATION | 2014 |
|
RU2587629C1 |
| STRAIN OF INFLUENZA VIRUS A/17/MALLARD/NETHERLANDS/00/95(H7N3) FOR PRODUCTION OF LIVE AND INACTIVATED INFLUENZA VACCINES | 2012 |
|
RU2507256C2 |
| INFLUENZA VIRUS STRAIN FOR PRODUCING LIVE AND INACTIVATED INFLUENZA VACCINE | 2011 |
|
RU2464309C1 |
| USING INFLUENZA VIRUS STRAIN A/17/NEW CALEDONIA/99/145 (H1N1) AS ATTENUATION DONOR FOR PRODUCING VACCINATING STRAINS OF LIVING INFLUENZA VACCINE SUBTYPE H2N2, VACCINATING INFLUENZA VIRUS STRAINS A/17/CALIFORNIA/66/4412 (H2N2) AND A/17/TOKYO/67/912 (H2N2) (VERSIONS) | 2011 |
|
RU2556834C2 |
| INFLUENZA VIRUS STRAIN INFLUBACT-H7/PSPA FOR THE PRODUCTION OF A COMBINED VACCINE AGAINST INFLUENZA A VIRUS AND BACTERIAL PNEUMONIA CAUSED BY STREPTOCOCCUS PNEUMONIAE | 2021 |
|
RU2776196C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/CALIFORNIA/04/6 (H3N2) AND ATTENUATION DONOR A/LENINGRAD/134/17/K7/57 (H2N2) FOR ITS PREPARING | 2006 |
|
RU2315101C2 |
| REASSORTANT INFLUENZA VIRUS STRAIN A/17/SILVER GULL/SARMA/06/887 (H6N1) FOR PREPARING LIVE INFLUENZA VACCINE | 2015 |
|
RU2606026C1 |
| VACCINE STRAIN OF INFLUENZA A/17/KANSAS/2017/631 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2732610C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/GUANGDONG-MAONAN/2019/211 (H1N1)PDM09 FOR PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2793387C1 |
